Motley Fool Australia

Creso Pharma Ltd (ASX: CPH) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $220.40 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.10 billion
Earnings per share -0.083
Dividend per share N/A
Year To Date Return 16.67%
Earnings Yield N/A
Franking N/A

Creso Pharma Ltd (ASX: CPH) Latest News

red arrow pointing down, falling share price

Why Cann, Creso, LiveTiles, & New Corp shares are tumbling lower today

More »

A man climbing stairs that go up and down in a chart style, indicating a moving share price

What’s happening with the Creso Pharma (ASX:CPH) share price today?

More »

shares valuation higher upgrade, growth shares

Why Blackmores, Creso Pharma, Pilbara Minerals, & Zip shares are pushing higher

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Here’s why the Creso Pharma (ASX:CPH) share price is rocketing 18% higher

More »

share price higher

Why Bingo, Creso Pharma, Domino’s, & Tyro shares are zooming higher today

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Why the Creso Pharma (ASX:CPH) share price is smoking the market today

More »

Stock market, ASX, investing

Afterpay and Creso Pharma were among the most traded shares on the ASX last week

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Here’s why the Creso Pharma (ASX:CPH) share price is jumping 13% higher today

More »

About Creso Pharma Ltd (ASX: CPH)

Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe andMiddle East regions.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
12 Apr 2021 $0.20 $-0.01 -4.76% 16,688,839 $0.21 $0.22 $0.20
09 Apr 2021 $0.21 $0.01 4.88% 12,160,566 $0.21 $0.22 $0.21
08 Apr 2021 $0.21 $0.01 5.13% 10,349,197 $0.20 $0.21 $0.20
07 Apr 2021 $0.20 $-0.01 -5.00% 15,068,041 $0.20 $0.21 $0.20
06 Apr 2021 $0.20 $-0.01 -4.76% 29,294,486 $0.20 $0.21 $0.20
01 Apr 2021 $0.21 $0.01 5.00% 11,882,115 $0.21 $0.21 $0.20
31 Mar 2021 $0.20 $0.00 0.00% 20,163,483 $0.20 $0.21 $0.20
30 Mar 2021 $0.20 $-0.02 -9.30% 25,710,743 $0.22 $0.22 $0.20
29 Mar 2021 $0.22 $-0.03 -12.50% 26,168,693 $0.24 $0.25 $0.22
26 Mar 2021 $0.24 $0.01 4.35% 49,109,553 $0.21 $0.25 $0.21
23 Mar 2021 $0.23 $0.02 9.52% 21,946,383 $0.22 $0.24 $0.22
22 Mar 2021 $0.21 $-0.01 -4.55% 7,061,937 $0.22 $0.22 $0.21
19 Mar 2021 $0.22 $-0.01 -4.35% 20,781,564 $0.22 $0.23 $0.22
18 Mar 2021 $0.23 $0.04 21.05% 37,474,429 $0.20 $0.23 $0.19
17 Mar 2021 $0.19 $0.00 0.00% 9,432,443 $0.19 $0.20 $0.19
16 Mar 2021 $0.19 $-0.01 -5.00% 17,946,937 $0.21 $0.21 $0.19
15 Mar 2021 $0.20 $-0.01 -4.76% 24,418,282 $0.22 $0.23 $0.20
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Mar 2021 James Ellingford Transfer 797 $159,500
22 Jan 2021 Adam Blumenthal Issued 87 $18,879,575
23 Dec 2020 Adam Blumenthal Issued 137 $4,000,000
12 Oct 2020 Adam Blumenthal Issued 833 $49,999
12 Oct 2020 Miriam Wernli Issued 833 $49,999
02 Jun 2020 Adam Blumenthal Issued 12 $720,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Adam Blumenthal Non-Executive Director,Non-Executive Chairman Nov 2015
Dr James Anthony Ellingford Executive Director Nov 2015
Mr Boaz Wachtel Non-Executive Director Nov 2015
Mr Winton William Willesee Joint Company Secretary Oct 2018
Ms Erlyn Dale Joint Company Secretary Oct 2018
Christopher Grundy Chief Financial Officer
Winton William Willesee Joint Company Secretary
Erlyn Dale Joint Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Atlantic Capital Holdings Pty <Atlantic Capital A/C> 139,415,432 14.62%
Hsbc Custody Nominees (Australia) Limited 33,358,651 3.50%
Suburban Holdings Pty Ltd<The Suburban Super Fund A/C> 27,507,750 2.88%
Jamber Investments Pty Ltd <The Amber Schwarz Fam A/C> 20,200,000 2.12%
Citicorp Nominees Pty Limited 19,026,497 2.00%
Mr William James Fleming 16,600,000 1.74%
Miriam Halperin Wernli 13,333,333 1.40%
J P Morgan Nominees Australia Pty Limited 8,764,097 0.92%
International Water & Energy Savers Ltd 8,300,000 0.87%
RS Family Holdings Pty Ltd <The Ruth Simon Family A/C> 8,158,803 0.86%
Anglo Australasia Holdings Pty Ltd <Anglo Australasia A/C> 7,083,333 0.74%
Mr Lisheng Wang 5,050,000 0.53%
Mr Kenneth Joseph Hall <Hall Park A/C> 5,000,000 0.52%
Chincherinchee Nominees Pty Ltd 4,436,427 0.47%
S3 Consortium Holdings Pty Ltd <Nextinvestors Dot Com A/C> 4,300,000 0.45%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 4,205,098 0.44%
Tenorio Pty Limited <Tenorio A/C> 3,581,427 0.38%
Mr Matthew Clarke Mallet 3,400,000 0.36%
Ubs Nominees Pty Ltd 3,192,251 0.33%
Comsec Nominees Pty Limited 3,176,508 0.33%
Show more